The Administrative Core Component 1 contains the centralized administrative functions pertaining to all 4Scientific Components, the Biostatistics Core Component (2), the Animal Core Component (3), and theEducation Core Component (4). The Administrative Core will also coordinate the scientific oversightprovided by the Scientific Advisory Board, including review of Pilot Projects, and educational enrichment asprovided by such activities as workshops. Administrative support will be provided for animal production(selection), genomics, statistical analyses both within and across components, educational enrichment andtraining, as well as setting and evaluating progress toward meeting research goals. Quality control will be animportant theme guiding oversight by the Administrative Core, which includes the Executive Committee thatevaluates progress towards scientific goals. Thus, the Administrative Core is structured to address twospecific aims.
Specific Aim 1 : The Core provides budgetary oversight and the general coordination of allCenter activities, supervised by Dr. Janowsky.
Specific Aim 2 : The Core coordinates communication amongCenter investigators via a secured shared drive on the University network, and the dissemination ofinformation to outside entities, including other investigators and Centers, via the Methamphetamine AbuseResearch Center (MARC) web site. Drs. Janowsky and Phillips coordinate future planning for scientificdirections, with the advise of the Executive Committee and Scientific Advisory Board.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Specialized Center (P50)
Project #
5P50DA018165-03
Application #
7700037
Study Section
Special Emphasis Panel (ZDA1-RXL-E (03))
Project Start
2008-07-01
Project End
2011-06-30
Budget Start
2008-07-01
Budget End
2009-06-30
Support Year
3
Fiscal Year
2008
Total Cost
$101,604
Indirect Cost
Name
Oregon Health and Science University
Department
Type
DUNS #
096997515
City
Portland
State
OR
Country
United States
Zip Code
97239
Holton, Dwight; White, Elizabeth; McCarty, Dennis (2018) Public Health Policy Strategies to Address the Opioid Epidemic. Clin Pharmacol Ther 103:959-962
Kohno, Milky; Loftis, Jennifer M; Huckans, Marilyn et al. (2018) The relationship between interleukin-6 and functional connectivity in methamphetamine users. Neurosci Lett 677:49-54
Shabani, Shkelzen; Schmidt, Bryan; Ghimire, Bikalpa et al. (2018) Depression-like symptoms of withdrawal in a genetic mouse model of binge methamphetamine intake. Genes Brain Behav :e12533
Eshleman, Amy J; Nagarajan, Shanthi; Wolfrum, Katherine M et al. (2018) Structure-activity relationships of bath salt components: substituted cathinones and benzofurans at biogenic amine transporters. Psychopharmacology (Berl) :
McCready, Holly; Kohno, Milky; Kolessar, Michael et al. (2018) Functional MRI and delay discounting in patients infected with hepatitis C. J Neurovirol 24:738-751
Loftis, Jennifer M; Valerio, Juno; Taylor, Jonathan et al. (2018) S100B and Inflammatory Cytokine Levels in Blood as Potential Markers of Blood-Brain Barrier Damage and Psychiatric Impairment in Comorbid Hepatitis C Viral Infection and Alcohol Use Disorder. Alcohol Clin Exp Res :
Eshleman, Amy J; Wolfrum, Katherine M; Reed, John F et al. (2018) Neurochemical pharmacology of psychoactive substituted N-benzylphenethylamines: High potency agonists at 5-HT2A receptors. Biochem Pharmacol 158:27-34
Tosh, Dilip K; Ciancetta, Antonella; Mannes, Philip et al. (2018) Repurposing of a Nucleoside Scaffold from Adenosine Receptor Agonists to Opioid Receptor Antagonists. ACS Omega 3:12658-12678
McCarty, Dennis; Priest, Kelsey C; Korthuis, P Todd (2018) Treatment and Prevention of Opioid Use Disorder: Challenges and Opportunities. Annu Rev Public Health 39:525-541
Eastwood, Emily C; Eshleman, Amy J; Janowsky, Aaron et al. (2018) Verification of a genetic locus for methamphetamine intake and the impact of morphine. Mamm Genome 29:260-272

Showing the most recent 10 out of 143 publications